ロード中...
MicroRNA Signature in Renal Cell Carcinoma
Renal cell carcinoma (RCC) includes 2.2% of all diagnosed cancers and 1.8% of cancer-related mortalities. The available biomarkers or screening methods for RCC suffer from lack of sensitivity or high cost, necessitating identification of novel biomarkers that facilitate early diagnosis of this cance...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734191/ https://ncbi.nlm.nih.gov/pubmed/33330087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.596359 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|